Stock Market & Financial Investment News

News Breaks January 7, 2013 14:01 EDT ACOR Acorda Therapeutics sees FY13 AMPYRA U.S. net sales $285M-$315M Sees other revenue of $25M (FAMPYRA and Zanaflex), which includes $9.1M in amortized license revenue. Comment from slides that will be presented at the 31st Annual JP Morgan Healthcare Conference. News For ACOR From The Last 14 Days Check below for free stories on ACOR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:12 EDT ACOR Acorda Therapeutics says issued additional U.S. patent for AMPYRA Subscribe for More Information May 9, 2013 10:11 EDT ACOR Acorda Therapeutics has a conference call hosted by JPMorgan Subscribe for More Information 07:05 EDT ACOR Acorda says data support initiation of current dalfampridine development program Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.